Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation

Flecainide is a frequently used antiarrhythmic drug, recommended by current guidelines as a first-line treatment option for restoring and maintaining sinus rhythm in patients with atrial fibrillation and no significant structural heart disease. In overdose, it can induce severe cardiogenic shock. Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gjermeni, Erind, Bollmann, Andreas, Hindricks, Gerhard, Müssigbrodt, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885768/
https://www.ncbi.nlm.nih.gov/pubmed/31827935
http://dx.doi.org/10.1155/2019/4820652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885768/
https://www.ncbi.nlm.nih.gov/pubmed/31827935
http://dx.doi.org/10.1155/2019/4820652

Ejemplares similares